Skip to main content
. Author manuscript; available in PMC: 2010 Feb 19.
Published in final edited form as: Ann Intern Med. 2009 Apr 7;150(7):437–446. doi: 10.7326/0003-4819-150-7-200904070-00003

Table 1.

Baseline Characteristics of Study Participants

Characteristic Total

(n = 750)
PM

(n = 250)
MDM

(n = 249)
HDM

(n = 251)
Age, mean (SD), y 47.2 (13.1) 47.1 (13.4) 48.2 (12.4) 46.4 (13.5)
Female, No. (%) 439 (58.5) 144 (57.6) 144 (57.8) 151 (60.2)
≤High school graduate, No. (%) 385 (51.3) 128 (51.2) 129 (51.8) 128 (51.0)
No. of cigarettes smoked per day, mean (SD) 23.7 (10.4) 24.3 (11.0) 23.8 (10.3) 22.9 (10.0)
Fagerström score, mean (SD)* 5.2 (2.2) 5.2 (2.2) 5.2 (2.2) 5.0 (2.1)
Previous use of bupropion, No. (%) 245 (32.7) 83 (33.2) 74 (29.7) 88 (35.1)
Previous use of nicotine replacement, No. (%) 397 (52.9) 128 (51.2) 128 (51.4) 141 (56.2)
Other smokers in household, No. (%) 345 (46.0) 119 (47.6) 116 (46.6) 110 (43.8)
Motivation to quit, mean (SD) 8.7 (2.1) 8.7 (2.0) 8.6 (2.2) 8.6 (2.0)
Confidence to quit, mean (SD) 6.1 (2.7) 5.9 (2.7) 6.1 (2.8) 6.3 (2.6)
Precontemplation stage of change, No. (%) 65 (8.7) 22 (8.8 20 (8.0) 23 (9.2)
Contemplation stage of change, No. (%) 457 (60.9) 158 (63.2) 153 (61.5) 146 (58.2)
Preparation stage of change, No. (%) 228 (30.4) 70 (28.0) 76 (30.5) 82 (32.7)
Hypertension, No. (%) 258 (34.4) 95 (38.0) 78 (31.3) 85 (33.9)
Hyperlipidemia, No. (%) 269 (35.9) 91 (36.4) 86 (34.5) 92 (36.7)
Diabetes, No. (%) 101 (13.5) 43 (17.2) 30 (12.1) 28 (11.2)
Chronic lung disease, No. (%) 202 (26.9) 65 (26.0) 73 (29.3) 64 (25.5)
Heart disease, No. (%) 73 (9.7) 24 (9.6) 29 (11.7) 20 (8.0)
History of depression, No. (%) 304 (40.5) 107 (42.8) 96 (38.6) 101 (40.2)

PM = pharmacotherapy management; MDM = moderate-intensity disease management; HDM = high-intensity disease management.

*

Fagerström test score for nicotine dependence ranges from 0 to 10. Scores of 6 or higher indicate greater levels of nicotine dependence.

Motivation and confidence to quit smoking scores range from 0 to 10